Evolving strains of multi-drug resistant pathogens are a growing global concern, outpacing drug discovery efforts and undermining the efficacy of existing antibiotics. The development of comprehensive diagnostics for clinical applications will become crucial to control escalating health risks. Existing laboratory tests to diagnose infectious disease are generally carried out via culture-based methods that usually take days to generate results. Rapid molecular diagnostic tests can comparatively i...
READ MORE
|
A New Year often rings in higher drug prices, and many top drugmakers marked the occasion in just that way this year. List price increases hit dozens of drugs, including staple drugs and blockbuster hopefuls. None of the increases, however, topped the 10% price-hike cap that's been trendy in pharma since 2016. In specialty pharma, Allergan, Teva, Collectis, Insys, Synergy and Supernus all raised prices effective Jan. 1, according to Jefferies analysts. Allergan changed its stickers on 18 med...
FIERCEPHARMA
READ MORE
|
Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications....
READ MORE
|
AMSBIO has introduced a range of purified cancer exosome samples to help researchers study the role of exosomes in cancer development and metastasis.By targeted filtration of patient serum using a specific binding method removes protein contaminant to isolate exosome at 95% high purity....
READ MORE
|
Over 500 new gene regions that influence people's blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by the Queen Mary University of London and Imperial College London. Involving more than one million participants, the results more than triple the number of blood pressure gene regions to over 1,000 and means that almost a third of the estimated heritability for blood pressure is now explained. The study, published in Nature Genetics and sup...
UNIVERSITY OF LONDON
READ MORE
|
The Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) announced that they have entered into a worldwide collaboration with Theravance Biopharma Ireland, a subsidiary of Theravance Biopharma, to develop TD-1473, an oral, gastrointestinal (GI) restricted pan-Janus kinase (JAK) inhibitor, and related back-up compounds for treating inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis (UC). The deal is potentially worth approximately $1 billion....
PHARMACEUTICAL TECHNOLOGY MAGAZINE
READ MORE
|